Vivian Reckers‐Droog

Severity-Adjusted Probability of Being Cost Effective

Matthijs Versteegh, Isaac Corro Ramos, Nasuh Büyükkaramikli et al. · PharmacoEconomics · 2019 · 83 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Methodological choices in applications of Q methodology: A systematic literature review

Charlotte Dieteren, Nathalie Patty, Vivian Reckers‐Droog et al. · Social Sciences & Humanities Open · 2023 · 80 citations · Full text

Social Sciences, Information Systems, Communication Research Methods +15

Equity Weights for Priority Setting in Healthcare: Severity, Age, or Both?

Vivian Reckers‐Droog, Job van Exel, Werner Brouwer · Value in Health · 2019 · 62 citations · Full text

Business, Health Policy, Decision Analysis +16

Willingness to Pay for Health-Related Quality of Life Gains in Relation to Disease Severity and the Age of Patients

Vivian Reckers‐Droog, Job van Exel, Werner Brouwer · Value in Health · 2021 · 52 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16

Why Do Adults Value EQ-5D-Y-3L Health States Differently for Themselves Than for Children and Adolescents: A Think-Aloud Study

Vivian Reckers‐Droog, Milad Karimi, Stefan A. Lipman et al. · Value in Health · 2022 · 45 citations · Full text

Pharmacy, Child Health, Health Sciences +13